Integrative biomarker discovery in neurodegenerative diseases

Wiley Interdiscip Rev Syst Biol Med. 2015 Nov-Dec;7(6):357-79. doi: 10.1002/wsbm.1310. Epub 2015 Jul 2.

Abstract

Data mining has been widely applied in biomarker discovery resulting in significant findings of different clinical and biological biomarkers. With developments in technology, from genomics to proteomics analysis, a deluge of data has become available, as well as standardized data repositories. Nonetheless, researchers are still facing important challenges in analyzing the data, especially when considering the complexity of pathways involved in biological processes and diseases. Data from single sources appear unable to explain complex processes, such as those involved in brain-related disorders, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, thus raising the need for a more comprehensive perspective. A possible solution relies on data and model integration, where several data types are combined to provide complementary views. This in turn can result in the discovery of previously unknown biomarkers by unraveling otherwise hidden relationships between data from different sources, and/or validate such composite biomarkers in more powerful predictive models.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers / metabolism*
  • Genome-Wide Association Study
  • Genomics
  • Humans
  • Models, Theoretical
  • Neurodegenerative Diseases / metabolism
  • Neurodegenerative Diseases / pathology*
  • Proteomics

Substances

  • Biomarkers